Pulmonaryhypertensionnews.com21h
Weight-based Uptravi dosing appropriate for PAH children: Study
A body weight-adjusted regimen of Uptravi dosing for children and adolescents with PAH was deemed appropriate, according to a ...
Pulmonaryhypertensionnews.com21h
PH can impose physical restrictions, but don’t limit yourself
Living with PH, it's easy to focus on what we can't do instead of what we can. Columnist Colleen Steele's advice? Don't limit ...
Pulmonaryhypertensionnews.com5d
Alivegen’s ALG-801 named FDA orphan drug for PAH
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ALG-801, Alivegen ’s experimental ...
Pulmonaryhypertensionnews.com3d
Phase 2 trial of tiprelestat for PAH receives FDA advice
The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial ...
Pulmonaryhypertensionnews.com10d
CS1 expanded access program for PAH now covers 10 patients
Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.
Pulmonaryhypertensionnews.com5d
How I struggle to manage chronic pain during the holidays
Chronic pain can be particularly difficult to manage during the holidays, says columnist Jen Cueva, who shares how PH disrupted her plans.
Pulmonaryhypertensionnews.com7d
Raising PH awareness is one of my New Year’s good intentions
As columnist Colleen Steele sets her intentions for 2025, she promises the PH community that she will continue raising awareness.